Teeft.i
Checkpoint
Istex
Racine
Checkpoint
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration H2N2 - Checkpoint (Istex)

Index « Teeft.i » - entrée « Vaccine virus »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccine type < Vaccine virus < Vaccine virus strain  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000564 (2004) Manjusha J. Gaglani [États-Unis] ; Gayla B. Herschler [États-Unis]Every Nose Counts: A New Influenza Vaccine for All Healthy Schoolchildren?
000671 (2001) J. M. Wood [Royaume-Uni] ; K. G. Nicholson [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; R. Hinton [Royaume-Uni] ; D. L. Major [Royaume-Uni] ; R. W. Newman [Royaume-Uni] ; U. Dunleavy [Royaume-Uni] ; D. Melzack [Royaume-Uni] ; J. S. Robertson [Royaume-Uni] ; G. C. Schild [Royaume-Uni]Developing vaccines against potential pandemic influenza viruses
000695 (2001) M. D Wareing [Australie] ; G. A Tannock [Australie]Live attenuated vaccines against influenza; an historical review
000708 (2001) H. G. G. Townsend [Canada] ; S. J. Penner [États-Unis] ; T. C. Watts [Canada] ; A. Cook [Canada] ; J. Bogdan [Canada] ; D. M. Haines [Canada] ; S. Griffin [Canada] ; T. Chambers [États-Unis] ; R. E. Holland [États-Unis] ; P. Whitaker-Dowling [États-Unis] ; J. S. Youngner [États-Unis] ; R. W. Sebring [États-Unis]Efficacy of a cold‐adapted, intranasal, equine influenza vaccine: challenge trials
000711 (2001) Alexander C. Schmidt [États-Unis] ; Robert B. Couch [États-Unis] ; George J. Galasso [États-Unis] ; Frederick G. Hayden [États-Unis] ; John Mills [Australie] ; Brian R. Murphy [États-Unis] ; Robert M. Chanock [États-Unis]Current research on respiratory viral infections: Third International Symposium
000751 (2000) T. G. Boyce [États-Unis] ; G. A. Poland [États-Unis]Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review
000828 (1999) Masanori Terajima ; Julie Jameson ; Joyce E. Norman ; John Cruz ; Francis A. EnnisHigh-Yield Reassortant Influenza Vaccine Production Virus Has a Mutation at an HLA-A 2.1-Restricted CD8+ CTL Epitope on the NS1 Protein
000C12 (1994) Harumi Kuno-Sakai [Japon] ; Mikio Kimura [Japon] ; Kazuyo Ohta [Japon] ; Rumi Shimojima [Japon] ; Yasumasa Oh [Japon] ; Hideo Fukumi [Japon]Developments in mucosal influenza virus vaccines
000C24 (1993) R. Pyh L [Finlande] ; L. Kinnunen [Finlande] ; V. Kumpulainen [Finlande] ; N. Ikonen [Finlande] ; M. Kleemola [Finlande] ; K. Cantell [Finlande]Vaccination-induced HI antibody to influenza A(H1N1) viruses in poorly primed adults under circumstances of low antigenic drift
000F77 (1988) Robert F. Betts [États-Unis] ; R. Gordon Douglas ; Hunien F. Maassab Jr. ; Dan C. Deborde ; Mary Lou Clements [États-Unis] ; Brian R. MurphyAnalysis of virus and host factors in a study of A/Peking/2/79 (H3N2) cold‐adapted vaccine recombinant in which vaccine‐associated illness occurred in normal volunteers
001088 (1986) Kathryn M. Edwards [États-Unis] ; Paula Snyder [États-Unis] ; Juliette M. Thompson [États-Unis] ; Philip R. Johnson [États-Unis] ; Peter F. Wright [États-Unis]In vitro production of anti-influenza virus antibody after simultaneous administration of H3N2 and H1N1 cold-adapted vaccines in seronegative children
001129 (1985) H. F. Maassab [États-Unis] ; Dan C. Deborde [États-Unis]Development and characterization of cold-adapted viruses for use as live virus vaccines
001151 (1985) Philip R. Johnson Jr. [États-Unis] ; Sandor Feldman ; Juliette M. Thompson ; Josephine D. Mahoney ; Peter F. WrightComparison of long‐term systemic and secretory antibody responses in children given live, attenuated, or inactivated influenza A vaccine
001162 (1984) Sir Charles Stuart-Harris [Grèce]Trials of live attenuated influenza virus vaccine in patients with chronic obstructive airways disease
001441 (1980) Friso Van Voorthuizen [Pays-Bas] ; Dorine Jens [Pays-Bas] ; Frans Saes [Pays-Bas]Characterization and clinical evaluation of live influenza a vaccine prepared from a recombinant of the A/USSR/92/77 (H1N1) and the cold-adapted A/Ann Arbor/6/60 (H2N2) strains
001462 (1980) R. A. Heijtink [Pays-Bas] ; N. Masurel [Pays-Bas] ; W. Weimar [Pays-Bas] ; S. W. Schalm [Pays-Bas]Influenza vaccination in HBsAg positive chronic active hepatitis patients treated with interferon
001532 (1979) G. C. SchildThe influenza virus: Antigenic composition and immune response.
001699 (1976) M. A. J. Moffat [Royaume-Uni] ; V. M. Stealey [Royaume-Uni] ; D. S. Freestone [Royaume-Uni] ; A. Macdonald [Royaume-Uni]Assessment of elicited antibody responses, clinical reactions and transmissibility of WRL 105 live influenza vaccine
001752 (1975) Peter F. Wright [États-Unis] ; Sarah H. Sell [États-Unis] ; Tatsuhiko Shinozaki [États-Unis] ; Juliette Thompson [États-Unis] ; David T. Karzon [États-Unis]Safety and antigenicity of influenza A/Hong Kong/68-ts-1 [E] (H3N2) vaccine in young seronegative children
001772 (1974) R. Jennings ; C. M. Brand [Royaume-Uni] ; C. Mclaren ; Lynda Shepherd ; C. W. PotterThe immune response of hamsters to purified haemagglutinins and whole influenza virus vaccines following live influenza virus infection

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Vaccine virus" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Vaccine virus" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Vaccine virus
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021